These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 19258717)

  • 1. Predictive value of the phosphorylation of signal transducers and activators of transcription in the outcome of interferon therapy for chronic hepatitis C.
    Miyaaki H; Ichikawa T; Nakao K; Takeshita S; Shibata H; Ozawa E; Akiyama M; Miuma S; Eguchi K
    Intervirology; 2008; 51(6):394-9. PubMed ID: 19258717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver expression of proteins controlling interferon-mediated signalling as predictive factors in the response to therapy in patients with hepatitis C virus infection.
    Bautista D; Bermúdez-Silva FJ; Lasarte JJ; Rodriguez-Fonseca F; Baixeras E
    J Pathol; 2007 Nov; 213(3):347-55. PubMed ID: 17940994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered expression and activation of signal transducers and activators of transcription (STATs) in hepatitis C virus infection: in vivo and in vitro studies.
    Larrea E; Aldabe R; Molano E; Fernandez-Rodriguez CM; Ametzazurra A; Civeira MP; Prieto J
    Gut; 2006 Aug; 55(8):1188-96. PubMed ID: 16120756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time course of insulin resistance during antiviral therapy in non-diabetic, non-cirrhotic patients with genotype 1 HCV infection.
    Petta S; Cammà C; Di Marco V; Cabibi D; Ciminnisi S; Caldarella R; Licata A; Massenti MF; Marchesini G; Craxì A
    Antivir Ther; 2009; 14(5):631-9. PubMed ID: 19704165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Melanoma cells exhibit variable signal transducer and activator of transcription 1 phosphorylation and a reduced response to IFN-alpha compared with immune effector cells.
    Lesinski GB; Trefry J; Brasdovich M; Kondadasula SV; Sackey K; Zimmerer JM; Chaudhury AR; Yu L; Zhang X; Crespin TR; Walker MJ; Carson WE
    Clin Cancer Res; 2007 Sep; 13(17):5010-9. PubMed ID: 17785551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Necessities of interferon therapy in elderly patients with chronic hepatitis C.
    Ikeda K; Arase Y; Kawamura Y; Yatsuji H; Sezaki H; Hosaka T; Akuta N; Kobayashi M; Saitoh S; Suzuki F; Suzuki Y; Kumada H
    Am J Med; 2009 May; 122(5):479-86. PubMed ID: 19375558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of hepatocellular carcinoma developed after achieving sustained virological response to interferon therapy for hepatitis C.
    Sanefuji K; Kayashima H; Iguchi T; Sugimachi K; Yamashita Y; Yoshizumi T; Soejima Y; Nishizaki T; Taketomi A; Maehara Y
    J Surg Oncol; 2009 Jan; 99(1):32-7. PubMed ID: 18985618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficient killing of SW480 colon carcinoma cells by a signal transducer and activator of transcription (STAT) 3 hairpin decoy oligodeoxynucleotide--interference with interferon-gamma-STAT1-mediated killing.
    Tadlaoui Hbibi A; Laguillier C; Souissi I; Lesage D; Le Coquil S; Cao A; Metelev V; Baran-Marszak F; Fagard R
    FEBS J; 2009 May; 276(9):2505-15. PubMed ID: 19476491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HCV core expression in hepatocytes protects against autoimmune liver injury and promotes liver regeneration in mice.
    Kawamura H; Govindarajan S; Aswad F; Machida K; Lai MM; Sung VM; Dennert G
    Hepatology; 2006 Oct; 44(4):936-44. PubMed ID: 17006910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystal structure of unphosphorylated STAT3 core fragment.
    Ren Z; Mao X; Mertens C; Krishnaraj R; Qin J; Mandal PK; Romanowski MJ; McMurray JS; Chen X
    Biochem Biophys Res Commun; 2008 Sep; 374(1):1-5. PubMed ID: 18433722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eradication of hepatitis C virus by interferon improves whole-body insulin resistance and hyperinsulinaemia in patients with chronic hepatitis C.
    Kawaguchi Y; Mizuta T; Oza N; Takahashi H; Ario K; Yoshimura T; Eguchi Y; Ozaki I; Hisatomi A; Fujimoto K
    Liver Int; 2009 Jul; 29(6):871-7. PubMed ID: 19302179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A liver slice culture-based ex vivo assay to predict the outcome of antiviral therapy for chronic hepatitis C.
    Chang ML; Sung KF; Sheen IS; Lin SM; Yeh CT
    J Viral Hepat; 2009 May; 16(5):359-66. PubMed ID: 19243501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A polymorphism in MAPKAPK3 affects response to interferon therapy for chronic hepatitis C.
    Tsukada H; Ochi H; Maekawa T; Abe H; Fujimoto Y; Tsuge M; Takahashi H; Kumada H; Kamatani N; Nakamura Y; Chayama K
    Gastroenterology; 2009 May; 136(5):1796-805.e6. PubMed ID: 19208361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of the nonstructural protein 4B of hepatitis C virus as a factor that inhibits the antiviral activity of interferon-alpha.
    Xu J; Liu S; Xu Y; Tien P; Gao G
    Virus Res; 2009 Apr; 141(1):55-62. PubMed ID: 19185598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver fibrosis and hepatic stellate cells improvement of chronic hepatitis C patients by interferon-beta-1a with or without sustained viral response.
    Rao HY; Wei L; Li J; Zhang LF; Chen HY; Zhu LM; Liu F; Sun Y; Wang H
    Hepatogastroenterology; 2009; 56(90):328-34. PubMed ID: 19579592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Artificial neural network model is superior to logistic regression model in predicting treatment outcomes of interferon-based combination therapy in patients with chronic hepatitis C.
    Wang CH; Mo LR; Lin RC; Kuo JJ; Chang KK; Wu JJ
    Intervirology; 2008; 51(1):14-20. PubMed ID: 18309244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EGF-induced apoptosis in A431 cells is dependent on STAT1, but not on STAT3.
    Grudinkin PS; Zenin VV; Kropotov AV; Dorosh VN; Nikolsky NN
    Eur J Cell Biol; 2007 Oct; 86(10):591-603. PubMed ID: 17646016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of 6-hydroxydopamine on the levels of phosphorylation of signal transduction and transcription factor 1 and 3: experiment with dopaminergic neurons].
    Wang LL; Chen B; Xu SL
    Zhonghua Yi Xue Za Zhi; 2007 Apr; 87(15):1048-52. PubMed ID: 17672970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of transferrin receptor 2 in hepatic accumulation of iron in patients with chronic hepatitis C.
    Mifuji R; Kobayashi Y; Ma N; Qiang QL; Urawa N; Horiike S; Iwasa M; Kaito M; Malavasi F; Adachi Y
    J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):144-51. PubMed ID: 16706826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver function under interferon/ribavirin therapy of chronic hepatitis C.
    Stintzing S; Schmitt C; Ocker M; Ganslmayer M; Zopf S; Gahr S; Hahn EG; Herold C
    Hepatogastroenterology; 2009; 56(90):462-5. PubMed ID: 19579621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.